Zymenex A/S

Zymenex develops pharmaceutical products to treat rare, serious and genetic diseases. The company’s goal is to develop a successive number of enzyme replacement therapies for diseases, which may have an orphan drug potential. 

Contact name:

Jens Fogh


Roskildevej 12 C, 3400 Hillerød, Denmark

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2010 Danskbiotek. All rights reserved.